| 000 | 01011 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514163134.0 | ||
| 264 | 0 | _c20040206 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a0362-5664 | ||
| 024 | 7 |
_a10.1097/00002826-200311000-00002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIsbister, Geoffrey K | |
| 245 | 0 | 0 |
_aAdverse reactions to mirtazapine are unlikely to be serotonin toxicity. _h[electronic resource] |
| 260 |
_bClinical neuropharmacology _c |
||
| 300 |
_a287-8; author reply 289-90 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMianserin _xadverse effects |
| 650 | 0 | 4 | _aMirtazapine |
| 650 | 0 | 4 |
_aSerotonin Syndrome _xchemically induced |
| 700 | 1 | _aWhyte, Ian M | |
| 773 | 0 |
_tClinical neuropharmacology _gvol. 26 _gno. 6 _gp. 287-8; author reply 289-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002826-200311000-00002 _zAvailable from publisher's website |
| 999 |
_c14381192 _d14381192 |
||